| Title | Therapeutic Advances in Musculoskeletal Disease |
| Abbreviation | Ther. Adv. Musculoskelet. Dis. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Orthopedics and Sports Medicine (Q1); Rheumatology (Q1) |
| h-index | 54 |
| Overall Rank/Ranking | 2903 |
| SCImago Journal Rank (SJR) | 1.348 |
| Impact Score | 4.14 |
| Publisher | SAGE Publications Inc. |
| Country | United Kingdom |
| ISSN | 1759720X, 17597218 |
| Best Quartile | Q1 |
| Coverage History | 2009-2025 |
Therapeutic Advances in Musculoskeletal Disease is a journal covering the technologies/fields/categories related to Orthopedics and Sports Medicine (Q1); Rheumatology (Q1). It is published by SAGE Publications Inc.. The overall rank of Therapeutic Advances in Musculoskeletal Disease is 2903. According to SCImago Journal Rank (SJR), this journal is ranked 1.348. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 54. The best quartile for this journal is Q1.
The ISSN of Therapeutic Advances in Musculoskeletal Disease journal is 1759720X, 17597218. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Musculoskeletal Disease is cited by a total of 1113 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Therapeutic Advances in Musculoskeletal Disease is 4.14, which is computed in 2025 as per its definition. Therapeutic Advances in Musculoskeletal Disease IF is increased by a factor of 0.65 and approximate percentage change is 18.62% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Therapeutic Advances in Musculoskeletal Disease is 4.14. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.14 |
| 2023 | 3.49 |
| 2022 | 4.02 |
| 2021 | 3.36 |
| 2020 | 4.29 |
| 2019 | 4.90 |
| 2018 | 4.76 |
| 2017 | 3.40 |
| 2016 | 3.10 |
| 2015 | 5.00 |
| 2014 | 4.69 |
Therapeutic Advances in Musculoskeletal Disease has an h-index of 54. It means 54 articles of this journal have more than 54 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Musculoskeletal Disease is 1759720X, 17597218. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Musculoskeletal Disease is 2903. According to SCImago Journal Rank (SJR), this journal is ranked 1.348. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.348 |
| 2023 | 1.061 |
| 2022 | 1.102 |
| 2021 | 0.818 |
| 2020 | 1.387 |
| 2019 | 1.475 |
| 2018 | 1.566 |
| 2017 | 1.118 |
| 2016 | 1.245 |
| 2015 | 1.318 |
| 2014 | 1.187 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 2903 |
| 2023 | 4004 |
| 2022 | 3588 |
| 2021 | 5544 |
| 2020 | 2614 |
| 2019 | 2300 |
| 2018 | 2084 |
| 2017 | 3733 |
| 2016 | 3160 |
| 2015 | 2961 |
| 2014 | 3370 |
Therapeutic Advances in Musculoskeletal Disease is published by SAGE Publications Inc.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2009-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Musculoskeletal Disease is Ther. Adv. Musculoskelet. Dis.. This abbreviation ('Ther. Adv. Musculoskelet. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Orthopedics and Sports Medicine (Q1); Rheumatology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Musculoskeletal Disease latest impact IF is 4.14. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 5.00 (2015) and 3.10 (2016), respectively, in the last 11 years. Moreover, its average IS is 4.1 in the previous 11 years.
The Therapeutic Advances in Musculoskeletal Disease has an SJR (SCImago Journal Rank) of 1.348, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.566 in 2018 and the lowest being 0.818 in 2021. Furthermore, the average SJR of the Therapeutic Advances in Musculoskeletal Disease over the previous 11-year period stands at 4.1.
The latest h-index of the Therapeutic Advances in Musculoskeletal Disease is 54.
The Therapeutic Advances in Musculoskeletal Disease is published by the SAGE Publications Inc., with its country of publication being the United Kingdom.
The Therapeutic Advances in Musculoskeletal Disease is currently ranked 2903 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2084 in 2018 and its lowest position of 5544 in 2021.
The standard ISO4 abbreviation for the Therapeutic Advances in Musculoskeletal Disease is Ther. Adv. Musculoskelet. Dis..
Therapeutic Advances in Musculoskeletal Disease is classified as a journal that the SAGE Publications Inc. publishes.
The Therapeutic Advances in Musculoskeletal Disease encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Musculoskeletal Disease is assigned the following International Standard Serial Numbers (ISSN): 1759720X, 17597218.
The best quartile for the Therapeutic Advances in Musculoskeletal Disease is Q1 (2024).
The Therapeutic Advances in Musculoskeletal Disease coverage history can be summarized as follows: 2009-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Applied Ecology and Environmental Research | journal | 19122 | Corvinus University of Budapest | 48 | 0.84 |
| Modern Language Journal | journal | 1033 | Wiley-Blackwell | 123 | 3.95 |
| Exploration Geophysics | journal | 18330 | Taylor and Francis Ltd. | 52 | 0.90 |
| Built Environment | journal | 16252 | Alexandrine Press | 51 | 0.95 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 | |
| European Journal of Cancer, Supplement | journal | 13149 | Elsevier Ltd | 30 | 0.00 |
| International Journal of Organizational Analysis | journal | 6012 | Emerald Group Publishing Ltd. | 47 | 6.23 |
| Perspectives in health information management / AHIMA, American Health Information Management Association | journal | 11411 | American Health Information Management Association | 33 | 2.54 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 4.14 |
| 2023 | 3.49 |
| 2022 | 4.02 |
| 2021 | 3.36 |
| 2020 | 4.29 |
| 2019 | 4.90 |
| 2018 | 4.76 |
| 2017 | 3.40 |
| 2016 | 3.10 |
| 2015 | 5.00 |
| 2014 | 4.69 |
